The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey.
about
Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver diseaseThe epidemiology and risk factors of chronic polyneuropathyDiabetic neuropathy: one disease or two?The metabolic syndromePro198Leu missense polymorphism of the glutathione peroxidase 1 gene might be a common genetic predisposition of distal symmetric polyneuropathy and macrovascular disease in Japanese type 2 diabetic patientsHuman glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress.The significance of screening for microvascular diseases in Chinese community-based subjects with various metabolic abnormalitiesAlcohol and HCV chronic infection are risk cofactors of type 2 diabetes mellitus for hepatocellular carcinoma in Italy.Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma.Impact of Fenofibrate on Type 2 Diabetes Patients with Features of the Metabolic Syndrome: Subgroup Analysis From FIELD.Diabetic neuropathy: clinical manifestations and current treatments.Prevalence of Metabolic Syndrome and its influence on microvascular complications in the Indian population with Type 2 Diabetes Mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 14).Metabolic Syndrome among Type-2 Diabetic Patients in Benghazi-Libya: A pilot study.The metabolic syndrome and severity of diabetic retinopathy.Prevalence of metabolic syndrome components in an urban Mexican sample: comparison between two classificationsDiabetes-specific nutrition algorithm: a transcultural program to optimize diabetes and prediabetes care.High Prevalence of Diabetic Retinopathy in Diabetic Patients Concomitant with Metabolic Syndrome.Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 DiabetesLiraglutide for treating type 1 diabetes.The impact of metabolic syndrome on retinal findings in patients with erectile dysfunction.Ferulic Acid Alleviates Changes in a Rat Model of Metabolic Syndrome Induced by High-Carbohydrate, High-Fat Diet.The Association of Metabolic Syndrome with Diabetic Retinopathy: The Korean National Health and Nutrition Examination Survey 2008-2012.Blood Glucose Control and Medication Adherence Among Adult Type 2 Diabetic Nigerians Attending A Primary Care Clinic in Under-resourced Environment of Eastern Nigeria.Cardiovascular Risk Factors Increase the Risks of Diabetic Peripheral Neuropathy in Patients With Type 2 Diabetes Mellitus: The Taiwan Diabetes StudyCardio-metabolic features of type 2 diabetes subjects discordant in the diagnosis of metabolic syndrome.Reducing vascular events risk in patients with dyslipidaemia: an update for cliniciansProfile of microvascular disease in type 2 diabetes in a tertiary health care hospital in IndiaMetabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status.Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesityCardiometabolic Risk Profiles in Patients With Impaired Fasting Glucose and/or Hemoglobin A1c 5.7% to 6.4%: Evidence for a Gradient According to Diagnostic Criteria: The PREDAPS Study.Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes.Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulinThe metabolic syndrome and neuropathy: therapeutic challenges and opportunities.Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population.Obesity, metabolic syndrome and diabetic retinopathy: Beyond hyperglycemia.Advanced bile acid-based multi-compartmental microencapsulated pancreatic β-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatment.Mediators of diabetic neuropathy: is hyperglycemia the only culprit?Peripheral neuropathy in prediabetes and the metabolic syndrome.Are Middle-Aged Men with Chronic Kidney Disease at Higher Risk of Having Nocturia than Age-Matched Controls.Neuroprotective effect of RYGB in Zucker fatty diabetic rats.
P2860
Q24655078-674B4DEB-A6FF-4651-B263-52B20D5EF82DQ26772148-B354C7FA-A583-4917-A9C8-67017D674673Q26859955-7FA06908-C636-47ED-9E82-90ECC3C230D8Q33569142-B8F53FE7-6196-46BD-89C7-E4688AE9CB19Q33585582-DE243194-1CE7-42A0-BAB5-3DB28987E0F0Q33589138-B3252B4A-4FA1-4DF1-81CD-C47DD5BEDE00Q33623669-010D9CC3-49BE-4A32-B4E7-71D35D6D6F8DQ33859074-ABFFD629-6D68-478F-9E68-AEABB565DD47Q33935606-41AE6ED4-EF2C-4A40-8A52-D22C127D888FQ33940875-1EF02971-2C65-4BBC-AFD8-AABB4A9D56D1Q34275990-50411125-B6E2-463D-B983-434C9ED5E6F8Q34360571-6F5CBF2E-9667-4608-9744-4BCCDFC7058CQ34780233-B557B23A-9039-470D-B0C6-3F6BDF2A052FQ35586571-12D3DF01-6E3B-4B78-82AC-EA8E2E4F224CQ35607305-C3B13F90-116D-4C88-BB47-73CE7D895EC0Q35828239-83E9792B-D135-414D-9810-F71AF6EABA8DQ35888609-B27EDF59-9262-4E44-B2DE-DA1855A2D27CQ35932408-789128EF-607F-4BDF-A7A6-11B240359193Q35939660-64D555BD-6E23-4A80-9CAB-754096C3BC27Q35993845-4280FCB8-ACE1-4F6D-BBDB-EAF8598B8098Q36012347-3F96FF4F-0405-4A7C-AB07-9C88BC0BFBF6Q36044969-0EF602C0-A76A-4778-A188-F885787E953DQ36132343-DDF41C06-A575-4F65-A69C-A12E65B0C9E9Q36207012-BA9AE5E9-8893-43F3-8F58-C69E37395A33Q36365233-DBF90E58-8CBF-465E-BC32-7FBF558DE7A3Q36443768-4C27CC0E-AA01-407C-A844-46C650EF312CQ36612834-1ADB83D6-4AB9-48B3-821F-D00D619813CFQ36820599-AC0233D8-6EFC-454F-A44B-EE8A01212BC7Q36846149-FF379737-5FC8-4F80-BB10-EDEE45F3C65DQ37026196-3D321A3D-AED4-430F-A3B8-3C86CFB3487FQ37163795-0BF48D49-5D84-4BB1-A97D-B9055E3359F7Q37356443-13C2C397-B391-4DD9-9510-B4FDBA08B1E0Q37436781-621FEE0F-2508-4BEF-9901-D0DAA983E87FQ38385395-59C81972-A227-40B4-A470-37A2D52FF680Q38656281-42C8C503-C3E2-4DC5-B97B-0450AFBA3E0EQ38943790-C8C9DB69-2604-41A9-947F-B0F7044823A0Q39015184-00F3DFFC-5F67-41EB-8964-8353819B41B7Q39165929-DC6E274B-3706-468A-9299-8997B2B3FE69Q40873090-0D90E006-4559-4E01-B114-7A0A9D68B573Q43015815-5B4A97FE-0473-462D-BD1D-E3D45DCCA985
P2860
The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
The metabolic syndrome is a ri ...... diabetes clinic-based survey.
@en
The metabolic syndrome is a ri ...... diabetes clinic-based survey.
@nl
type
label
The metabolic syndrome is a ri ...... diabetes clinic-based survey.
@en
The metabolic syndrome is a ri ...... diabetes clinic-based survey.
@nl
prefLabel
The metabolic syndrome is a ri ...... diabetes clinic-based survey.
@en
The metabolic syndrome is a ri ...... diabetes clinic-based survey.
@nl
P2093
P356
P1433
P1476
The metabolic syndrome is a ri ...... diabetes clinic-based survey.
@en
P2093
Antonio Tiengo
Domenico Cucinotta
Domenico Fedele
Gabriele Riccardi
Metascreen Writing Committee
P304
P356
10.2337/DC06-0942
P407
P577
2006-12-01T00:00:00Z